Novartis honoured with Global Corporate Citizenship AwardDecember 2013
In recognition of its significant on-going contributions to malaria control and elimination, Novartis has been honoured with the Global Corporate Citizenship Award at the Malaria No More International Honors annual benefit.
Since 2001 Novartis has delivered more than 600m anti-malarial treatments to malaria-endemic countries across Africa, without profit.
The company also adopts an innovative approach in its long-standing efforts to eliminate malaria and has invested in partnerships to maximize the impact of its efforts.
In collaboration with Medicines for Malaria Venture, Novartis was first to develop a sweet-tasting dispersible artemisinin-based combination therapy (ACT) treatment specifically for infants and children, which was launched in 2009. In 2010, Novartis rolled out “SMS for Life”; a program which uses mobile technology to manage delivery and stock levels of life-saving antimalarial medicines for rural health facilities.
This year, Novartis joined forces with Malaria No More and supports the Power of One campaign to help close the treatment gap in Africa. ”
Already a member? click here to login